Savara Presented New Biomarker Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) ...
Czech researchers have discovered that nanoplastics can weaken the lungs’ natural defence system, raising fresh concerns ...
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, sponsored an oral presentation at the ATS 2026 International Conference that is taking place ...
ORJ-001 achieved therapeutic exposure and was well tolerated in Phase 1 study, supporting company’s plans to initiate Phase 2 clinical trial in IPF patients ...
Savara is transitioning from a single-asset biotech to a rare disease commercial infrastructure. Click here to read more on ...
PALM DESERT, Calif. (KESQ) - A multimillion dollar project tracking windblown dust hopes to target the Coachella Valley's poor air quality. The South Coast Air Quality Management District and CVAG ...
Galaxy Digital Inc. (the "Company" or "Galaxy"), a global leader in digital assets and data center infrastructure, today announced that the New York State Department of Financial Services (NYDFS) has ...
Non-small cell lung cancer (NSCLC) tumor markers are signs of specific types of tumors. Routine tumor markers doctors may test for after an NSCLC diagnosis include EGFR, ALK, and ROS1. Tumor markers ...
Detailed price information for Galaxy Entmnt Group Ord (GXYEF) from The Globe and Mail including charting and trades.
Introduction Congenital malformations (CMs) are the leading cause of infant mortality. Still, the aetiology remains unknown in 70% of cases. The most accepted hypothesis is that hereditary and ...
First Extensive Analysis of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in a Large Cohort of Patients With HIV-Associated Hodgkin Lymphoma: Baseline Total Metabolic ...
The couple “left it to God”, as an anxious team got to work at Moradabad’s TMU Hospital for a '1 in 7 lakh' delivery. A week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results